+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Viral Vector & Plasmid DNA Manufacturing Market Research Report by Cell Line, Type, Transfection, Indication, Workflow, Application, End User, Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4986033
  • Report
  • April 2022
  • Region: Global
  • 219 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • ABL Inc.
  • Biovian Oy
  • Creative Biogene
  • Kaneka Eurogentec S.A.
  • Miltenyi Biotec GmbH
  • Spark Therapeutics Inc.
The Global Viral Vector & Plasmid DNA Manufacturing Market size was estimated at USD 688.42 million in 2020, USD 860.08 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 25.05% to reach USD 2,632.73 million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Viral Vector & Plasmid DNA Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Cell Line, the market was studied across In-vitro and In-Vivo.
  • Based on Type, the market was studied across Adeno-Associated Virus, Adenovirus, Lentivirus, and Plasmid DNA.
  • Based on Transfection, the market was studied across Stable Transfection and Transient Transfection.
  • Based on Indication, the market was studied across Cancer, Genetic Disorder, and Infectious Disease.
  • Based on Workflow, the market was studied across Downstream Processing and Upstream Processing. The Downstream Processing is further studied across Fill-finish and Purification. The Upstream Processing is further studied across Vector Amplification & Expansion and Vector Recovery/Harvesting.
  • Based on Application, the market was studied across Antisense & RNAi, Cell Therapy, Gene Therapy, and Vaccinology.
  • Based on End User, the market was studied across Biotech Companies and Research Institutes.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Viral Vector & Plasmid DNA Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Viral Vector & Plasmid DNA Manufacturing Market, including ABL Inc., Batavia Biosciences B.V., BioNTech IMFS GmbH, Biovian Oy, c-LEcta GmbH, Cell and Gene Therapy Catapult, Cevec Pharmaceuticals GmbH, Cobra Biologics Limited, Creative Biogene, FinVector Vision Therapies, FUJIFILM Diosynth Biotechnologies Inc., GE Healthcare, GeneOne Life Science, Inc., Genezen Laboratories, Kaneka Eurogentec S.A., Lonza Group AG, Merck KGaA, Miltenyi Biotec GmbH, Novasep Inc., Sirion-Biotech GmbH, Spark Therapeutics Inc., Thermo Fisher Scientific Inc., uniQure N.V., Vigene Biosciences, Inc., and Wuxi AppTec Co., Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Viral Vector & Plasmid DNA Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Viral Vector & Plasmid DNA Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Viral Vector & Plasmid DNA Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Viral Vector & Plasmid DNA Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Viral Vector & Plasmid DNA Manufacturing Market?
6. What is the market share of the leading vendors in the Global Viral Vector & Plasmid DNA Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Viral Vector & Plasmid DNA Manufacturing Market?
Frequently Asked Questions about the Global Viral Vector & Plasmid DNA Manufacturing Market

What is the estimated value of the Global Viral Vector & Plasmid DNA Manufacturing Market?

The Global Viral Vector & Plasmid DNA Manufacturing Market was estimated to be valued at $688.4 Million in 2020.

What is the growth rate of the Global Viral Vector & Plasmid DNA Manufacturing Market?

The growth rate of the Global Viral Vector & Plasmid DNA Manufacturing Market is 25.0%, with an estimated value of $2632.7 Million by 2026.

What is the forecasted size of the Global Viral Vector & Plasmid DNA Manufacturing Market?

The Global Viral Vector & Plasmid DNA Manufacturing Market is estimated to be worth $2632.7 Million by 2026.

Who are the key companies in the Global Viral Vector & Plasmid DNA Manufacturing Market?

Key companies in the Global Viral Vector & Plasmid DNA Manufacturing Market include ABL Inc., Batavia Biosciences B.V., BioNTech IMFS GmbH, Biovian Oy, c, LEcta GmbH, Cell and Gene Therapy Catapult, Cevec Pharmaceuticals GmbH and Creative Biogene.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ABL Inc.
  • Biovian Oy
  • Creative Biogene
  • Kaneka Eurogentec S.A.
  • Miltenyi Biotec GmbH
  • Spark Therapeutics Inc.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising use of viral vectors in several treatments such as cancer demands developments in plasmids and vectors
5.1.1.2. Awareness on the benefits of gene therapy
5.1.1.3. Increase in funding for research and development activities
5.1.2. Restraints
5.1.2.1. Limited trained professionals and the complexity of the manufacturing process
5.1.3. Opportunities
5.1.3.1. Emerging demand for synthetic genes
5.1.3.2. Approval of gene therapy products from the FDA and other governing bodies
5.1.4. Challenges
5.1.4.1. Ethical concern, logistical issues, and associated cost
5.2. Cumulative Impact of COVID-19
6. Viral Vector & Plasmid DNA Manufacturing Market, by Cell Line
6.1. Introduction
6.2. In-vitro
6.3. In-Vivo
7. Viral Vector & Plasmid DNA Manufacturing Market, by Type
7.1. Introduction
7.2. Adeno-Associated Virus
7.3. Adenovirus
7.4. Lentivirus
7.5. Plasmid DNA
8. Viral Vector & Plasmid DNA Manufacturing Market, by Transfection
8.1. Introduction
8.2. Stable Transfection
8.3. Transient Transfection
9. Viral Vector & Plasmid DNA Manufacturing Market, by Indication
9.1. Introduction
9.2. Cancer
9.3. Genetic Disorder
9.4. Infectious Disease
10. Viral Vector & Plasmid DNA Manufacturing Market, by Workflow
10.1. Introduction
10.2. Downstream Processing
10.2.1. Fill-finish
10.2.2. Purification
10.3. Upstream Processing
10.3.1. Vector Amplification & Expansion
10.3.2. Vector Recovery/Harvesting
11. Viral Vector & Plasmid DNA Manufacturing Market, by Application
11.1. Introduction
11.2. Antisense & RNAi
11.3. Cell Therapy
11.4. Gene Therapy
11.5. Vaccinology
12. Viral Vector & Plasmid DNA Manufacturing Market, by End User
12.1. Introduction
12.2. Biotech Companies
12.3. Research Institutes
13. Americas Viral Vector & Plasmid DNA Manufacturing Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Viral Vector & Plasmid DNA Manufacturing Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
15. Europe, Middle East & Africa Viral Vector & Plasmid DNA Manufacturing Market
15.1. Introduction
15.2. France
15.3. Germany
15.4. Italy
15.5. Netherlands
15.6. Qatar
15.7. Russia
15.8. Saudi Arabia
15.9. South Africa
15.10. Spain
15.11. United Arab Emirates
15.12. United Kingdom
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. ABL Inc.
17.2. Batavia Biosciences B.V.
17.3. BioNTech IMFS GmbH
17.4. Biovian Oy
17.5. c-LEcta GmbH
17.6. Cell and Gene Therapy Catapult
17.7. Cevec Pharmaceuticals GmbH
17.8. Cobra Biologics Limited
17.9. Creative Biogene
17.10. FinVector Vision Therapies
17.11. FUJIFILM Diosynth Biotechnologies Inc.
17.12. GE Healthcare
17.13. GeneOne Life Science, Inc.
17.14. Genezen Laboratories
17.15. Kaneka Eurogentec S.A.
17.16. Lonza Group AG
17.17. Merck KGaA
17.18. Miltenyi Biotec GmbH
17.19. Novasep Inc.
17.20. Sirion-Biotech GmbH
17.21. Spark Therapeutics Inc.
17.22. Thermo Fisher Scientific Inc.
17.23. uniQure N.V.
17.24. Vigene Biosciences, Inc.
17.25. Wuxi AppTec Co., Ltd.
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: DYNAMICS
FIGURE 2. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2020 VS 2026 (%)
FIGURE 3. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2020 VS 2026 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2026
FIGURE 5. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 7. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 10. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2026
FIGURE 12. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2020 VS 2026 (%)
FIGURE 21. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2026
FIGURE 23. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
FIGURE 28. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2026
FIGURE 30. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2020 VS 2026 (%)
FIGURE 37. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2020 VS 2026 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2026
FIGURE 39. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, 2018-2026 (USD MILLION)
FIGURE 42. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 43. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 45. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2026 (USD MILLION)
FIGURE 46. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 47. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, 2018-2026 (USD MILLION)
FIGURE 48. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 49. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, 2018-2026 (USD MILLION)
FIGURE 50. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 51. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 52. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2026
FIGURE 54. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, 2018-2026 (USD MILLION)
FIGURE 55. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 56. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, 2018-2026 (USD MILLION)
FIGURE 57. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 58. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, 2018-2026 (USD MILLION)
FIGURE 59. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 60. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, 2018-2026 (USD MILLION)
FIGURE 61. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 62. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 63. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2026
FIGURE 65. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2026 (USD MILLION)
FIGURE 66. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 67. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 68. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 69. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 80. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 82. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 83. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 84. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 85. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 86. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 87. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 88. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 89. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 90. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 91. NETHERLANDS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 92. QATAR VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 93. RUSSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 94. SAUDI ARABIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 95. SOUTH AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 96. SPAIN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 97. UNITED ARAB EMIRATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 98. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 99. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: FPNV POSITIONING MATRIX
FIGURE 100. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 101. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VITRO, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY IN-VIVO, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ADENOVIRUS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY LENTIVIRUS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY STATE, 2018-2026 (USD MILLION)
TABLE 33. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 35. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSFECTION, 2018-2026 (USD MILLION)
TABLE 36. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 37. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 38. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, BY STATE, 2018-2026 (USD MILLION)
TABLE 39. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STABLE TRANSFECTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 41. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 42. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 43. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, BY STATE, 2018-2026 (USD MILLION)
TABLE 44. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TRANSIENT TRANSFECTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 46. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INDICATION, 2018-2026 (USD MILLION)
TABLE 47. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 48. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 49. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, BY STATE, 2018-2026 (USD MILLION)
TABLE 50. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 52. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2018-2026 (USD MILLION)
TABLE 53. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 54. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, BY STATE, 2018-2026 (USD MILLION)
TABLE 55. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENETIC DISORDER, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 57. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 58. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 59. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY STATE, 2018-2026 (USD MILLION)
TABLE 60. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 62. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY WORKFLOW, 2018-2026 (USD MILLION)
TABLE 63. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2026 (USD MILLION)
TABLE 64. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 65. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY STATE, 2018-2026 (USD MILLION)
TABLE 66. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 68. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, BY REGION, 2018-2026 (USD MILLION)
TABLE 69. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 70. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, BY STATE, 2018-2026 (USD MILLION)
TABLE 71. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILL-FINISH, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 73. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 74. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 75. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 76. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 78. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2026 (USD MILLION)
TABLE 79. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 80. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY STATE, 2018-2026 (USD MILLION)
TABLE 81. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 83. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, BY REGION, 2018-2026 (USD MILLION)
TABLE 84. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 85. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, BY STATE, 2018-2026 (USD MILLION)
TABLE 86. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR AMPLIFICATION & EXPANSION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 88. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 89. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 90. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 91. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VECTOR RECOVERY/HARVESTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 93. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 94. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, BY REGION, 2018-2026 (USD MILLION)
TABLE 95. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 96. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, BY STATE, 2018-2026 (USD MILLION)
TABLE 97. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANTISENSE & RNAI, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 99. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 100. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 101. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY STATE, 2018-2026 (USD MILLION)
TABLE 102. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 104. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 105. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 106. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY STATE, 2018-2026 (USD MILLION)
TABLE 107. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 109. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 110. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 111. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 112. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINOLOGY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 114. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 115. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 116. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 117. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 118. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 120. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 121. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 122. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 123. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 125. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 126. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 127. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 128. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 129. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 130. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 131. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 132. AUSTRALIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 133. CHINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 134. INDIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 135. INDONESIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 136. JAPAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 137. MALAYSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 138. PHILIPPINES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 139. SINGAPORE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 140. SOUTH KOREA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 141. TAIWAN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 142. THAILAND VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 144. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 145. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 146. ITALY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 147. NETHERLANDS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 148. QATAR VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 149. RUSSIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 150. SAUDI ARABIA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 151. SOUTH AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 152. SPAIN VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 154. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 155. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: SCORES
TABLE 156. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: BUSINESS STRATEGY
TABLE 157. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: PRODUCT SATISFACTION
TABLE 158. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: RANKING
TABLE 159. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 160. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: MERGER & ACQUISITION
TABLE 161. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 162. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 163. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: INVESTMENT & FUNDING
TABLE 164. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 165. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • ABL Inc.
  • Batavia Biosciences B.V.
  • BioNTech IMFS GmbH
  • Biovian Oy
  • c-LEcta GmbH
  • Cell and Gene Therapy Catapult
  • Cevec Pharmaceuticals GmbH
  • Cobra Biologics Limited
  • Creative Biogene
  • FinVector Vision Therapies
  • FUJIFILM Diosynth Biotechnologies Inc.
  • GE Healthcare
  • GeneOne Life Science, Inc.
  • Genezen Laboratories
  • Kaneka Eurogentec S.A.
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • Novasep Inc.
  • Sirion-Biotech GmbH
  • Spark Therapeutics Inc.
  • Thermo Fisher Scientific Inc.
  • uniQure N.V.
  • Vigene Biosciences, Inc.
  • Wuxi AppTec Co., Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...